DE69111642T2 - Gabapentin und dessen Derivate zur Behandlung neurodegenerativer Krankheiten. - Google Patents
Gabapentin und dessen Derivate zur Behandlung neurodegenerativer Krankheiten.Info
- Publication number
- DE69111642T2 DE69111642T2 DE69111642T DE69111642T DE69111642T2 DE 69111642 T2 DE69111642 T2 DE 69111642T2 DE 69111642 T DE69111642 T DE 69111642T DE 69111642 T DE69111642 T DE 69111642T DE 69111642 T2 DE69111642 T2 DE 69111642T2
- Authority
- DE
- Germany
- Prior art keywords
- gabapentin
- derivatives
- treatment
- neurodegenerative diseases
- huntington
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45991290A | 1990-01-02 | 1990-01-02 | |
US07/615,151 US5084479A (en) | 1990-01-02 | 1990-11-23 | Novel methods for treating neurodegenerative diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69111642D1 DE69111642D1 (de) | 1995-09-07 |
DE69111642T2 true DE69111642T2 (de) | 1996-01-25 |
Family
ID=27039510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69111642T Expired - Fee Related DE69111642T2 (de) | 1990-01-02 | 1991-01-02 | Gabapentin und dessen Derivate zur Behandlung neurodegenerativer Krankheiten. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5084479A (de) |
EP (1) | EP0446570B1 (de) |
JP (1) | JP2903434B2 (de) |
AT (1) | ATE125701T1 (de) |
DE (1) | DE69111642T2 (de) |
DK (1) | DK0446570T3 (de) |
HK (1) | HK1005166A1 (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5025035A (en) * | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
US5217957A (en) * | 1991-08-20 | 1993-06-08 | Warner-Lambert Company | Cholecystokinin antagonists useful for treating depression |
US5792796A (en) * | 1994-07-27 | 1998-08-11 | Warner-Lambert Company | Methods for treating anxiety and panic |
US5510381A (en) * | 1995-05-15 | 1996-04-23 | Warner-Lambert Company | Method of treatment of mania and bipolar disorder |
ATE207878T1 (de) * | 1996-03-14 | 2001-11-15 | Warner Lambert Co | Zyklische aminosäure als pharmazeutische wirkstoffe |
US6372792B1 (en) | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
SI0934061T1 (en) | 1996-07-24 | 2003-10-31 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
PL193237B1 (pl) * | 1997-06-30 | 2007-01-31 | Merz Pharma Gmbh & Co Kgaa | Pochodne 1-aminoalkilocykloheksanu, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie |
WO1999008667A2 (en) | 1997-08-19 | 1999-02-25 | Warner-Lambert Company | Methods for treating physiological conditions associated with the use, or sequelae of use, of ***e or other psychomotor stimulants |
AU9318398A (en) | 1997-10-07 | 1999-04-27 | Warner-Lambert Company | Process for preparing a cyclic amino acid anticonvulsant compound |
NZ503651A (en) * | 1997-10-27 | 2002-09-27 | Warner Lambert Co | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
DE19751062A1 (de) * | 1997-11-18 | 1999-07-08 | Univ Ludwigs Albert | An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels |
US6984659B2 (en) | 1997-11-18 | 2006-01-10 | Klinikum Der Albert-Ludwigs Universitaet | 2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level |
EP1077692B1 (de) * | 1998-05-15 | 2004-07-28 | Warner-Lambert Company LLC | Aminosäure-stabilisierte gabapentin und pregabalin zubereitungen und verfahren zu ihrer herstellung |
WO1999059572A1 (en) * | 1998-05-15 | 1999-11-25 | Warner-Lambert Company | Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
US6294198B1 (en) | 1999-08-24 | 2001-09-25 | Purepac Pharmaceutical Co. | Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same |
FR2801217B1 (fr) * | 1999-11-24 | 2002-12-06 | Aventis Pharma Sa | Association de riluzole et de gabapentine et son utilisation comme medicament |
US6350768B1 (en) | 1999-11-24 | 2002-02-26 | Aventis Pharma S.A. | Combination of riluzole and of gabapentin and its use as a medicament |
AU2001266992B8 (en) * | 2000-06-16 | 2005-12-01 | Teva Pharmaceutical Industries Ltd. | Stable gabapentin having pH within a controlled range |
EP1289364B1 (de) | 2000-06-16 | 2003-12-10 | Teva Pharmaceutical Industries Ltd. | Stabiles gabapentin, das mehr als 20 ppm chlor enthält |
NZ522480A (en) * | 2000-06-26 | 2005-06-24 | Warner Lambert Co | Gabapentin analogues for sleep disorders |
US7056951B2 (en) | 2000-09-26 | 2006-06-06 | Mutual Pharmaceutical Co., Inc. | Stable solid dosage forms of amino acids and processes for producing same |
US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7232924B2 (en) * | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
WO2002100344A2 (en) * | 2001-06-11 | 2002-12-19 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
HUP0400183A2 (hu) * | 2001-06-11 | 2004-07-28 | Xenoport Inc. | Gaba-analóg prodrugok csökkentett toxicitású orális dózisformái |
US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US20070184104A1 (en) * | 2001-10-25 | 2007-08-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
US20060159743A1 (en) * | 2001-10-25 | 2006-07-20 | Depomed, Inc. | Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
US7612112B2 (en) | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
TWI312285B (en) * | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
US20030119908A1 (en) * | 2001-12-21 | 2003-06-26 | Zambon Group S.P.A. | Stable gabapentin compositions |
ITMI20012750A1 (it) | 2001-12-21 | 2003-06-21 | Procos Spa | Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura |
AU2003210486B2 (en) * | 2002-01-16 | 2007-06-28 | Endo Pharmaceuticals Inc. | Pharmaceutical composition and method for treating disorders of the central nervous system |
US6927036B2 (en) * | 2002-02-19 | 2005-08-09 | Xero Port, Inc. | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
AU2003262383A1 (en) * | 2002-04-16 | 2003-11-03 | Taro Pharmaceutical Industries Ltd. | Process for preparing gabapentin |
WO2003099338A2 (en) * | 2002-05-17 | 2003-12-04 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
AU2003297927A1 (en) | 2002-12-11 | 2004-06-30 | Xenoport, Inc. | Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
US20040162351A1 (en) * | 2002-12-11 | 2004-08-19 | Gallop Mark A. | Orally administered dosage forms of fused GABA analog prodrugs having reduced toxicity |
CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
WO2005000294A1 (en) * | 2003-06-06 | 2005-01-06 | Pharmacia Corporation | Selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders |
NZ545989A (en) | 2003-09-17 | 2009-10-30 | Xenoport Inc | Treating or preventing restless legs syndrome using prodrugs of gaba analogs |
MXPA06004088A (es) | 2003-10-14 | 2006-06-27 | Xenoport Inc | Forma cristalina de un analogo del acido gamma-aminobutirico. |
EP1737466A1 (de) * | 2004-01-29 | 2007-01-03 | Pfizer Products Inc. | KOMBINATION VON Y-AMINOBUTTERSÄURE-MODULATOREN UND 5HT-1b REZEPTOR-ANTAGONISTEN |
US20050187295A1 (en) * | 2004-02-19 | 2005-08-25 | Surendra Kalyan | Processes for the preparation of gabapentin |
ITMI20040579A1 (it) * | 2004-03-25 | 2004-06-25 | Zambon Spa | Processo di preparazione di gabapentina |
RU2440112C2 (ru) | 2004-11-04 | 2012-01-20 | Ксенопорт, Инк. | Пероральная дозированная форма габапентина замедленного высвобождения |
US20090176882A1 (en) | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
IN2012MN02923A (de) | 2010-06-01 | 2015-06-05 | Rubicon Res Private Ltd | |
EP2923694B1 (de) | 2014-03-27 | 2018-11-14 | Sanovel Ilac Sanayi ve Ticaret A.S. | Orale flüssige pharmazeutische lösung von gabapentin |
WO2021079887A1 (ja) * | 2019-10-25 | 2021-04-29 | 国立大学法人京都大学 | タウオパチーの予防又は治療剤 |
CN115350172A (zh) * | 2022-08-12 | 2022-11-18 | 昆明医科大学 | Gabapentin对AD情景记忆改善的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
1990
- 1990-11-23 US US07/615,151 patent/US5084479A/en not_active Expired - Lifetime
- 1990-12-27 JP JP2418309A patent/JP2903434B2/ja not_active Expired - Fee Related
-
1991
- 1991-01-02 DK DK91100109.7T patent/DK0446570T3/da active
- 1991-01-02 EP EP91100109A patent/EP0446570B1/de not_active Expired - Lifetime
- 1991-01-02 AT AT91100109T patent/ATE125701T1/de not_active IP Right Cessation
- 1991-01-02 DE DE69111642T patent/DE69111642T2/de not_active Expired - Fee Related
-
1998
- 1998-05-15 HK HK98104232A patent/HK1005166A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE125701T1 (de) | 1995-08-15 |
DK0446570T3 (da) | 1995-11-27 |
JPH04210915A (ja) | 1992-08-03 |
US5084479A (en) | 1992-01-28 |
HK1005166A1 (en) | 1998-12-24 |
DE69111642D1 (de) | 1995-09-07 |
EP0446570B1 (de) | 1995-08-02 |
JP2903434B2 (ja) | 1999-06-07 |
EP0446570A3 (en) | 1992-04-01 |
EP0446570A2 (de) | 1991-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69111642D1 (de) | Gabapentin und dessen Derivate zur Behandlung neurodegenerativer Krankheiten. | |
DE60124080D1 (de) | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit | |
UY26813A1 (es) | Compuestos para tratar enfermedad de alzheimer | |
DE60116313D1 (de) | Verbindungen zur behandlung der alzheimerischen krankheit | |
ATE478669T1 (de) | Zusammenstellungen und methoden zur behandlung der alzheimerschen krankheit, schäden des zentralnervensystems und entzündlichen erkrankungen | |
DE60124085D1 (de) | Pde-v hemmer zur behandlung von morbus parkinson | |
ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
TW229156B (de) | ||
DE69716810T2 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
NZ234672A (en) | N-(1,2,3,4-tetrahydro-9-acridinyl)amide and carbamate derivatives and pharmaceutical compositions | |
ATE526981T1 (de) | Verwendung von vegf 165 und homologen zur behandlung von neurologischen störungen | |
ATE268337T1 (de) | C11-carbamate von antibakteriellen makroliden | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
DE3854121T2 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
ATE180669T1 (de) | Verwendung von pregnanderivaten zur behandlung von tumoren | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
ATE239470T1 (de) | Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen | |
DE69911689D1 (de) | Verfahren zur Herstellung von S-Aryl-L-cystein und Derivate | |
DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
DE69916577D1 (de) | Azetidincarboxamid-derivate zur behandlung von zns störungen | |
DE69930880D1 (de) | Bicyclische(3.1.0)hexane und verwandte Verbindungen | |
HUT56559A (en) | Process for producing ascorbinic acid derivatives and pharma | |
DE69026991T2 (de) | Phospholipide zur Behandlung der multiplen Sklerose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |